Категории

Therapy Options for Hepatitis B/C–Related HCC

Опубликовано: 09 Апрель 2020
на канале: OncLive
2,082
24

Key opinion leaders discuss their preference of first-line treatment for patients with hepatitis B– and C–related hepatocellular carcinoma.

Смотрите видео Therapy Options for Hepatitis B/C–Related HCC онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь OncLive 09 Апрель 2020, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 2,082 раз и оно понравилось 24 людям.

play_arrow
1,085
10

Guide Life is Feudal: Your Own #2 - Как сделать веревку

Guide Life is Feudal: Your Own #2 - Как сделать веревку
play_arrow
131,841
178

Halo 3 Mods Part 1 !!!No Joke!!!

Halo 3 Mods Part 1 !!!No Joke!!!
play_arrow
37
3

Прохождение игры Rogue Legacy часть 2 (1 Повержен, осталось четверо)

Прохождение игры Rogue Legacy часть 2 (1 Повержен, осталось четверо)
play_arrow
35
1

Happy Wheels ВНИЗ ПО ЛЕСТНИЦЕ И УНЫЛЫЕ ИСТОРИИ

Happy Wheels ВНИЗ ПО ЛЕСТНИЦЕ И УНЫЛЫЕ ИСТОРИИ
play_arrow
209
14

MORGENSHTERN - ДУЛО | ХИТ 2021 | Новая Песня | НА ОТКРЫТЫХ СТРУНАХ!

MORGENSHTERN - ДУЛО | ХИТ 2021 | Новая Песня | НА ОТКРЫТЫХ СТРУНАХ!
play_arrow
1,162
130

Раскрываем истинную сущность власти и прислуги. Подкаст №1.

Раскрываем истинную сущность власти и прислуги. Подкаст №1.
play_arrow
631
12

ЕГЭ Обществознание: Понятие власти

ЕГЭ Обществознание: Понятие власти
play_arrow
43
2

Прохождение Игры Rogue Legacy 1

Прохождение Игры Rogue Legacy 1
Похожие видео
play_arrow
Precision Medicine in Metastatic Triple Negative Breast Cancer

Precision Medicine in Metastatic Triple Negative Breast Cancer
play_arrow
Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion
play_arrow
EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer
play_arrow
OncLive News Network On Location: ASCO 2020 Day 1

OncLive News Network On Location: ASCO 2020 Day 1
play_arrow
Diagnosis of Neurofibromatosis Type 1

Diagnosis of Neurofibromatosis Type 1
play_arrow
Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer

Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer
play_arrow
Novel Treatments in HER2-Positive Breast Cancer

Novel Treatments in HER2-Positive Breast Cancer
play_arrow
Lurbinectedin’s Role in Managing SCLC

Lurbinectedin’s Role in Managing SCLC
play_arrow
Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma

Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma
play_arrow
Therapy Options for Hepatitis B/C–Related HCC

Therapy Options for Hepatitis B/C–Related HCC
play_arrow
Treating Patients With Essential Thrombocytopenia

Treating Patients With Essential Thrombocytopenia
play_arrow
Biology of Clear Cell Renal Cell Carcinoma

Biology of Clear Cell Renal Cell Carcinoma
play_arrow
The Use of Ruxolitinib in Myelofibrosis

The Use of Ruxolitinib in Myelofibrosis
play_arrow
Current Treatment Landscape of Soft Tissue Sarcoma

Current Treatment Landscape of Soft Tissue Sarcoma
play_arrow
Diagnostic Testing Procedure for Soft Tissue Sarcoma

Diagnostic Testing Procedure for Soft Tissue Sarcoma
play_arrow
Treatment Landscape of Castrate-Resistant Prostate Cancer

Treatment Landscape of Castrate-Resistant Prostate Cancer
play_arrow
Lenalidomide in Del 5q MDS

Lenalidomide in Del 5q MDS
play_arrow
MDS: Low-Risk Disease Treatment Options

MDS: Low-Risk Disease Treatment Options
play_arrow
Neoadjuvant Treatment for Triple-Negative Breast Cancer

Neoadjuvant Treatment for Triple-Negative Breast Cancer
play_arrow
Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice

Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice
play_arrow
Dr. Tsao on Rationale for Staging Renal Cell Carcinoma

Dr. Tsao on Rationale for Staging Renal Cell Carcinoma
play_arrow
Cirrhosis Prognosis: The Child-Pugh Score

Cirrhosis Prognosis: The Child-Pugh Score
play_arrow
Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer

Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer
play_arrow
Dr. Corcoran on Targeting HER2 Amplification in CRC

Dr. Corcoran on Targeting HER2 Amplification in CRC